Anti-C1q antibody in patients with lupus nephritic flare: 18-month follow-up and a nested case-control study

References

• Yaniv G, Twig G, Shor DB, Furer A, Sherer Y, Mozes O, et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev. 2015;14(1):75–9.
   PubMed Web of Science ®Google Scholar
• Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum. 2004;34(2):501–37.
   PubMed Web of Science ®Google Scholar
• Uwatoko S, Aotsuka S, Okawa M, Egusa Y, Yokohari R, Aizawa C, et al. Characterization of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol. 1984;30(1):104-16.
   PubMedGoogle Scholar
• Trouw LA, Daha MR. Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis. Expert Opin Biol Ther. 2005;5(2):243–51.
   PubMed Web of Science ®Google Scholar
• Potlukova E, Kralikova P. Complement component c1q and anti-c1q antibodies in theory and in clinical practice. Scand J Immunol. 2008;67(5):423–30.
   PubMed Web of Science ®Google Scholar
• Orbai AM, Truedsson L, Sturfelt G, Nived O, Fang H, Alarcon G, et al. Anti-C1q antibodies in systemic lupus erythematosus. Lupus. 2014;24(1):42–9.
   PubMed Web of Science ®Google Scholar
• Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, et al. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Ann N Y Acad Sci. 2005;1050:193–200.
   PubMed Web of Science ®Google Scholar
• Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis. 2005;64(3):444–8.
   PubMed Web of Science ®Google Scholar
• Meyer OC, Nicaise-Roland P, Cadoudal N, Grootenboer-Mignot S, Palazzo E, Hayem G, et al. Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus. Arthritis Res Ther. 2009;11(3):R87.
   PubMed Web of Science ®Google Scholar
• Zhang CQ, Ren L, Gao F, Mu FY, You YQ, Liu YH. Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China. Clin Rheumatol. 2011;30(7):967–73.
   PubMed Web of Science ®Google Scholar
• Matrat A, Veysseyre-Balter C, Trolliet P, Villar E, Dijoud F, Bienvenu J, et al. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares. Lupus. 2011;20(1):28–34.
   PubMed Web of Science ®Google Scholar
• Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Lupus. 2011;20(12):1267–74.
   PubMed Web of Science ®Google Scholar
• Yin Y, Wu X, Shan G, Zhang X. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis. Lupus. 2012;21(10):1088–97.
   PubMed Web of Science ®Google Scholar
• Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol. 2000;76:227–324.
   PubMed Web of Science ®Google Scholar
• Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358(9):929–39.
   PubMed Web of Science ®Google Scholar
• Bigler C, Schaller M, Perahud I, Osthoff M, Trendelenburg M. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells. J Immunol. 2009 1;183(5):3512–21.
   PubMed Web of Science ®Google Scholar
• Pickering MC, Botto M. Are anti-C1q antibodies different from other SLE autoantibodies? Nat Rev Rheumatol. 2010;6(8):490–3.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Ibanez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288–91.
   PubMed Web of Science ®Google Scholar
• Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15(2):241–50.
   PubMed Web of Science ®Google Scholar
• Mok CC, Ho CT, Chan KW, Lau CS, Wong RW. Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine. Arthritis Rheum. 2002;46(4):1003–13.
   PubMed Web of Science ®Google Scholar
• Ruperto N, Hanrahan LM, Alarcon GS, Belmont HM, Brey RL, Brunetta P, et al. International consensus for a definition of disease flare in lupus. Lupus. 2011;20(5):453–62.
   PubMed Web of Science ®Google Scholar
• Mosca M, Merrill J, Bombardieri S. Assessment of disease activity in systemic lupus erythematosus. In: Tsokos G, Gordon C, Smolen J, eds. Systemic lupus erythematosus. Philadelphia (PA): Elsevier; 2007:19–23.
   Google Scholar
• Fang QY, Yu F, Tan Y, Xu LX, Wu LH, Liu G, et al. Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis. Nephrol Dial Transplant. 2009;24(1):172–8.
   PubMed Web of Science ®Google Scholar
• Moroni G, Trendelenburg M, Del Papa N, Quaglini S, Raschi E, Panzeri P, et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis. 2001;37(3):490–8.
   PubMed Web of Science ®Google Scholar
• Horak P, Hermanova Z, Zadrazil J, Ciferska H, Ordeltova M, Kusa L, et al. C1q complement component and antibodies reflect SLE activity and kidney involvement. Clin Rheumatol. 2006;25(4):532–6.
   PubMed Web of Science ®Google Scholar
• Gargiulo ML, Gomez G, Khoury M, Collado MV, Suarez L, Alvarez C, et al. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus. Medicina (B Aires). 2015;75(1):23–8.
   PubMed Web of Science ®Google Scholar
• Julkunen H, Ekblom-Kullberg S, Miettinen A. Non-renal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Rheumatol Int. 2012;32(8):2445–51.
   PubMed Web of Science ®Google Scholar
• Moura CG, Mangueira CL, Cruz LA, Cruz CM. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus. Nephron Clin Pract. 2011;118(4):c355–60.
   PubMed Web of Science ®Google Scholar
• Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, et al. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Arthritis Rheum. 2011;63(8):2436–44.
   PubMed Web of Science ®Google Scholar